Mankind Pharma Ltd (MANKIND) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.022x

Based on the latest financial reports, Mankind Pharma Ltd (MANKIND) has a cash flow conversion efficiency ratio of 0.022x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.93 Billion ≈ $20.87 Million USD) by net assets (Rs86.34 Billion ≈ $933.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Mankind Pharma Ltd financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Mankind Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Mankind Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Mankind Pharma Ltd market capitalisation for the company's overall valuation and market capitalisation.

Mankind Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mankind Pharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
QXO, Inc. NYSE:QXO	0.022x
American Financial Group, Inc. NYSE:AFG	0.101x
JBS N.V. NYSE:JBS	0.203x
Biomarin Pharmaceutical Inc NASDAQ:BMRN	0.036x
Gongniu Group Co Ltd SHG:603195	0.084x
Kratos Defense & Security Solutions NASDAQ:KTOS	-0.008x
EastGroup Properties Inc NYSE:EGP	0.040x
Elanco Animal Health NYSE:ELAN	0.002x

Annual Cash Flow Conversion Efficiency for Mankind Pharma Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of Mankind Pharma Ltd from 2019 to 2025. View Mankind Pharma Ltd (MANKIND) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs145.68 Billion ≈ $1.58 Billion	Rs24.13 Billion ≈ $261.00 Million	0.166x	-26.30%
2024-03-31	Rs95.76 Billion ≈ $1.04 Billion	Rs21.52 Billion ≈ $232.78 Million	0.225x	-5.18%
2023-03-31	Rs76.49 Billion ≈ $827.19 Million	Rs18.13 Billion ≈ $196.10 Million	0.237x	+62.80%
2022-03-31	Rs63.16 Billion ≈ $683.08 Million	Rs9.20 Billion ≈ $99.47 Million	0.146x	-37.73%
2021-03-31	Rs48.63 Billion ≈ $525.90 Million	Rs11.37 Billion ≈ $122.99 Million	0.234x	-19.73%
2020-03-31	Rs36.72 Billion ≈ $397.07 Million	Rs10.70 Billion ≈ $115.68 Million	0.291x	+44.69%
2019-03-31	Rs29.82 Billion ≈ $322.46 Million	Rs6.00 Billion ≈ $64.93 Million	0.201x	--

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$10.88 Billion

Rs1.01 Trillion INR

Market Cap Rank

#2118 Global

#90 in India

Share Price

Rs2438.00

Change (1 day)

-0.73%

52-Week Range

Rs1927.40 - Rs2660.60

All Time High

Rs2998.40